Amytrx Therapeutics, Inc. announced it raised $3.59 Million in an initial filing from an offering of $12 Million

Aug 12, 2020•about 5 years ago

Amount Raised

$3.59 Million

Round Type

seed

NashvilleHealthcare

Company Information

Company

Amytrx Therapeutics, Inc.

Location

102 Woodmont Blvd

Nashville, Arkansas, United States

About

Amytrx Therapeutics, Inc. is a Biopharmaceutical Drug Development Company with Innovative Peptide-based Solutions for Inflammation and Metabolic Syndrome.

Amytrx Therapeutics, Inc. announced it raised $3.59 Million in an initial filing from an offering of $12 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information